Summary
This study identifies CERS6 (ceramide synthase 6) as an overexpressed gene in non-small-cell lung cancer tissues that correlates with poor prognosis and lymph node metastasis. Using molecular and cellular approaches, the authors demonstrate that CERS6-mediated ceramide synthesis is necessary for cancer cell migration, invasion, and metastatic capacity, with overexpression promoted partly by reduced miR-101 expression. The findings suggest ceramide synthesis represents a potential therapeutic target in lung cancer metastasis.
UK applicability
As a basic cancer biology study conducted in cell culture and mouse models, the findings have potential relevance to UK lung cancer research and drug development programmes, though clinical translation and applicability to human disease would require further investigation.
Key measures
CERS6 gene expression levels; ceramide synthesis profiles; cell migration and invasion rates; RAC1-positive lamellipodia/ruffling formation; lung metastasis efficiency in mice; miR-101 expression levels
Outcomes reported
The study measured CERS6 gene expression in non-small-cell lung cancer tissues and cell lines, and assessed its role in cancer cell migration, invasion, and metastatic capacity using in vitro and in vivo mouse models. Key outcomes included altered ceramide profiles, reduced cell migration/invasion upon CERS6 knockdown, and suppressed lung metastasis in mice.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.